Technical Analysis for SNCE - Science 37 Holdings, Inc.

Grade Last Price % Change Price Change
D 5.75 0.35% 0.02
SNCE closed up 0.35 percent on Monday, March 11, 2024, on 1.14 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Flat

Date Alert Name Type % Chg
New Uptrend Bullish 0.00%
180 Bullish Setup Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Stochastic Reached Overbought Strength 0.00%
Earnings Movers Other 0.00%
Overbought Stochastic Strength 0.00%
Bollinger Band Squeeze Range Contraction 0.35%
Narrow Range Bar Range Contraction 0.35%
Bollinger Band Squeeze Range Contraction 0.35%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Science 37 Holdings, Inc. Description

Science 37's mission is to enable universal access to clinical research—making it easier for patients and providers to participate from nearly anywhere and helping to accelerate the development of treatments that impact patient lives. As a pioneer of decentralized clinical trials, the Science 37 Clinical Trial Operating System (OS) supports today’s more agile clinical research designs with its full stack, end-to-end technology platform and specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators and connected devices. Configurable to enable any study type, the Science 37 OS can enable up to 15x faster enrollment, 28% better retention and 3x more diverse patient population with industry-leading workflow orchestration, evidence generation and data harmonization.


Classification

Sector: Healthcare
Industry: Health Information Services
Keywords: Health Sciences Telehealth Operating System Telemedicine Health Informatics Clinical Research Clinical Trial Clinical Pharmacology

Is SNCE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 12.96
52 Week Low 3.73
Average Volume 43,164
200-Day Moving Average 5.84
50-Day Moving Average 5.60
20-Day Moving Average 5.72
10-Day Moving Average 5.73
Average True Range 0.09
RSI (14) 58.68
ADX 25.07
+DI 27.99
-DI 16.01
Chandelier Exit (Long, 3 ATRs) 5.49
Chandelier Exit (Short, 3 ATRs) 5.93
Upper Bollinger Bands 5.75
Lower Bollinger Band 5.69
Percent B (%b) 0.97
BandWidth 1.14
MACD Line 0.05
MACD Signal Line 0.06
MACD Histogram -0.0103
Fundamentals Value
Market Cap 34.66 Million
Num Shares 6.03 Million
EPS -21.40
Price-to-Earnings (P/E) Ratio -0.27
Price-to-Sales 0.57
Price-to-Book 0.66
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.78
Resistance 3 (R3) 5.78 5.76 5.78
Resistance 2 (R2) 5.76 5.76 5.77 5.77
Resistance 1 (R1) 5.76 5.75 5.76 5.76 5.77
Pivot Point 5.74 5.74 5.75 5.75 5.74
Support 1 (S1) 5.74 5.74 5.74 5.74 5.73
Support 2 (S2) 5.72 5.73 5.73 5.73
Support 3 (S3) 5.72 5.72 5.73
Support 4 (S4) 5.72